These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


887 related items for PubMed ID: 18543250

  • 21. Heat shock protein-90 (Hsp90) acts as a repressor of peroxisome proliferator-activated receptor-alpha (PPARalpha) and PPARbeta activity.
    Sumanasekera WK, Tien ES, Davis JW, Turpey R, Perdew GH, Vanden Heuvel JP.
    Biochemistry; 2003 Sep 16; 42(36):10726-35. PubMed ID: 12962497
    [Abstract] [Full Text] [Related]

  • 22. Differential responses of PPARalpha, PPARdelta, and PPARgamma reporter cell lines to selective PPAR synthetic ligands.
    Seimandi M, Lemaire G, Pillon A, Perrin A, Carlavan I, Voegel JJ, Vignon F, Nicolas JC, Balaguer P.
    Anal Biochem; 2005 Sep 01; 344(1):8-15. PubMed ID: 16038868
    [Abstract] [Full Text] [Related]

  • 23. Simultaneous, bidirectional inhibitory crosstalk between PPAR and STAT5b.
    Shipley JM, Waxman DJ.
    Toxicol Appl Pharmacol; 2004 Sep 15; 199(3):275-84. PubMed ID: 15364543
    [Abstract] [Full Text] [Related]

  • 24. Expression of PPARgamma and beta/delta in human primary osteoblastic cells: influence of polyunsaturated fatty acids.
    Maurin AC, Chavassieux PM, Meunier PJ.
    Calcif Tissue Int; 2005 May 15; 76(5):385-92. PubMed ID: 15868283
    [Abstract] [Full Text] [Related]

  • 25. Peroxisome proliferator-activated receptor-gamma agonists promote differentiation and antioxidant defenses of oligodendrocyte progenitor cells.
    Bernardo A, Bianchi D, Magnaghi V, Minghetti L.
    J Neuropathol Exp Neurol; 2009 Jul 15; 68(7):797-808. PubMed ID: 19535992
    [Abstract] [Full Text] [Related]

  • 26. Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells.
    Marx N, Duez H, Fruchart JC, Staels B.
    Circ Res; 2004 May 14; 94(9):1168-78. PubMed ID: 15142970
    [Abstract] [Full Text] [Related]

  • 27. Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells.
    Sertznig P, Dunlop T, Seifert M, Tilgen W, Reichrath J.
    Anticancer Res; 2009 Sep 14; 29(9):3647-58. PubMed ID: 19667161
    [Abstract] [Full Text] [Related]

  • 28. Peroxisome proliferator-activated receptors in squamous cell carcinoma and its precursors.
    Nijsten T, Geluyckens E, Colpaert C, Lambert J.
    J Cutan Pathol; 2005 May 14; 32(5):340-7. PubMed ID: 15811118
    [Abstract] [Full Text] [Related]

  • 29. Effect of medium- and long-chain fatty acid diets on PPAR and SREBP-1 expression and glucose homeostasis in ACBP-overexpressing transgenic rats.
    Oikari S, Ahtialansaari T, Huotari A, Kiehne K, Fölsch UR, Wolffram S, Jänne J, Alhonen L, Herzig KH.
    Acta Physiol (Oxf); 2008 Sep 14; 194(1):57-65. PubMed ID: 18394026
    [Abstract] [Full Text] [Related]

  • 30. Ligand-mediated regulation of peroxisome proliferator-activated receptor (PPAR) beta/delta: a comparative analysis of PPAR-selective agonists and all-trans retinoic acid.
    Rieck M, Meissner W, Ries S, Müller-Brüsselbach S, Müller R.
    Mol Pharmacol; 2008 Nov 14; 74(5):1269-77. PubMed ID: 18701617
    [Abstract] [Full Text] [Related]

  • 31. Peroxisome proliferator-activated receptor alpha, delta, gamma1 and gamma2 expressions are present in human monocyte-derived dendritic cells and modulate dendritic cell maturation by addition of subtype-specific ligands.
    Jakobsen MA, Petersen RK, Kristiansen K, Lange M, Lillevang ST.
    Scand J Immunol; 2006 May 14; 63(5):330-7. PubMed ID: 16640656
    [Abstract] [Full Text] [Related]

  • 32. PPARbeta/delta potentiates PPARgamma-stimulated adipocyte differentiation.
    Matsusue K, Peters JM, Gonzalez FJ.
    FASEB J; 2004 Sep 14; 18(12):1477-9. PubMed ID: 15247146
    [Abstract] [Full Text] [Related]

  • 33. Peroxisome proliferator-activated receptors as transcriptional nodal points and therapeutic targets.
    Brown JD, Plutzky J.
    Circulation; 2007 Jan 30; 115(4):518-33. PubMed ID: 17261671
    [Abstract] [Full Text] [Related]

  • 34. PPAR activation has dichotomous control on the expression levels of cytosolic and secretory phospholipase A2 in astrocytes; inhibition in naïve, untreated cells and enhancement in LPS-stimulated cells.
    Sergeeva MG, Aleshin SE, Grabeklis S, Reiser G.
    J Neurochem; 2010 Oct 30; 115(2):399-410. PubMed ID: 20670373
    [Abstract] [Full Text] [Related]

  • 35. Peroxisome-proliferator-activated receptors γ and β/δ mediate vascular endothelial growth factor production in colorectal tumor cells.
    Röhrl C, Kaindl U, Koneczny I, Hudec X, Baron DM, König JS, Marian B.
    J Cancer Res Clin Oncol; 2011 Jan 30; 137(1):29-39. PubMed ID: 20221637
    [Abstract] [Full Text] [Related]

  • 36. Metabolic action of peroxisome proliferator-activated receptor gamma agonism in rats with exogenous hypercorticosteronemia.
    Berthiaume M, Laplante M, Tchernof A, Deshaies Y.
    Int J Obes (Lond); 2007 Nov 30; 31(11):1660-70. PubMed ID: 17579631
    [Abstract] [Full Text] [Related]

  • 37. Double gene deletion reveals the lack of cooperation between PPARalpha and PPARbeta in skeletal muscle.
    Bedu E, Desplanches D, Pequignot J, Bordier B, Desvergne B.
    Biochem Biophys Res Commun; 2007 Jun 15; 357(4):877-81. PubMed ID: 17466944
    [Abstract] [Full Text] [Related]

  • 38. Characterization of Madin-Darby bovine kidney cell line for peroxisome proliferator-activated receptors: temporal response and sensitivity to fatty acids.
    Bionaz M, Baumrucker CR, Shirk E, Vanden Heuvel JP, Block E, Varga GA.
    J Dairy Sci; 2008 Jul 15; 91(7):2808-13. PubMed ID: 18565938
    [Abstract] [Full Text] [Related]

  • 39. Inhibition of in vivo glioma growth and invasion by peroxisome proliferator-activated receptor gamma agonist treatment.
    Grommes C, Landreth GE, Sastre M, Beck M, Feinstein DL, Jacobs AH, Schlegel U, Heneka MT.
    Mol Pharmacol; 2006 Nov 15; 70(5):1524-33. PubMed ID: 16887936
    [Abstract] [Full Text] [Related]

  • 40. Regulation of inflammation by PPARs: a future approach to treat lung inflammatory diseases?
    Becker J, Delayre-Orthez C, Frossard N, Pons F.
    Fundam Clin Pharmacol; 2006 Oct 15; 20(5):429-47. PubMed ID: 16968414
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 45.